
Friday, May 07, 2021 10:49:23 AM
Now bring on the news~
In My Own Personal Opinion Of Course!

Liked By
Spread the love. Be the first to like this post!
Recent ADMP News
- Quarterly Report (10-q) • Edgar (US Regulatory) • 11/14/2022 09:59:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 11/14/2022 09:48:05 PM
- Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 11/14/2022 09:10:07 PM
- Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 11/07/2022 09:05:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:16:15 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 10/04/2022 10:09:16 AM
- Adamis Announces Review of Strategic Alternatives • GlobeNewswire Inc. • 10/03/2022 08:30:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/23/2022 09:08:52 PM
- Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) • Edgar (US Regulatory) • 09/23/2022 09:06:45 PM
- Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/21/2022 11:30:00 AM
- Notice of Effectiveness (effect) • Edgar (US Regulatory) • 09/20/2022 10:03:49 AM
- Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk Subjects • GlobeNewswire Inc. • 09/12/2022 08:05:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 09/12/2022 10:05:18 AM
- Securities Registration Statement (simplified Form) (s-3) • Edgar (US Regulatory) • 09/09/2022 09:13:00 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/18/2022 07:09:02 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 08/15/2022 10:36:44 AM
- Adamis Pharmaceuticals Announces Results of Annual Meeting of Stockholders • GlobeNewswire Inc. • 08/12/2022 09:00:00 PM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/10/2022 08:11:23 PM
- Quarterly Report (10-q) • Edgar (US Regulatory) • 08/10/2022 08:05:21 PM
- Adamis Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 08/10/2022 08:02:00 PM
- Adamis Pharmaceuticals Schedules Second Quarter 2022 Financial Results Conference Call and Corporate Update • GlobeNewswire Inc. • 08/08/2022 11:30:00 AM
- Current Report Filing (8-k) • Edgar (US Regulatory) • 08/01/2022 01:38:08 PM
- Dawson James Sticks to Its Hold Rating for Adamis Pharma (ADMP) • TipRanks • 07/31/2022 12:15:25 PM
- Additional Proxy Soliciting Materials (definitive) (defa14a) • Edgar (US Regulatory) • 07/29/2022 07:36:42 PM
- Leading Independent Proxy Advisory Firm ISS Recommends Adamis Pharmaceuticals’ Stockholders Vote FOR Critical Proposals at Upcoming Annual Meeting • GlobeNewswire Inc. • 07/29/2022 12:00:00 PM
FEATURED Hempacco Pre-launches Snoop Dogg Brands at the Champs Trade Show in Las Vegas, February 8 - 11, Exhibiting with Death Row Vapes in Booth #1201 • Feb 6, 2023 9:30 AM
ILUS Summarizes Its Progress and Projections Following Its 2nd Annual Shareholder Meeting • ILUS • Feb 6, 2023 10:28 AM
Xalles Announces 2022 Results and Organizational Changes • XALL • Feb 6, 2023 8:39 AM
TNRG Signs Reg A Offering Agreement • TNRG • Feb 3, 2023 10:30 AM
Trend Innovations Holding Inc. Thy News Application Review Year 2022 and Update Toward 2023 • TREN • Feb 2, 2023 2:00 PM
Goldshore Intersects 9.46 g/t Au over 7.45m in the Southwest Zone Widths of Mineralized System Expanded Significantly. • GSHRF • Feb 2, 2023 9:58 AM